Thilo Hagen

5.5k total citations · 3 hit papers
74 papers, 4.7k citations indexed

About

Thilo Hagen is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Thilo Hagen has authored 74 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 19 papers in Cancer Research and 13 papers in Physiology. Recurrent topics in Thilo Hagen's work include Cancer, Hypoxia, and Metabolism (19 papers), Mitochondrial Function and Pathology (18 papers) and Ubiquitin and proteasome pathways (14 papers). Thilo Hagen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (19 papers), Mitochondrial Function and Pathology (18 papers) and Ubiquitin and proteasome pathways (14 papers). Thilo Hagen collaborates with scholars based in Singapore, United Kingdom and United States. Thilo Hagen's co-authors include Bradford B. Lowell, Olivier Boss, Salvador Moncada, Francis Lam, Cormac T. Taylor, Antonio Vidal‐Puig, Chenyu Zhang, Danica Grujić, Vamsi K. Mootha and Eng‐Hui Chew and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thilo Hagen

70 papers receiving 4.6k citations

Hit Papers

Uncoupling Protein-2 Nega... 2000 2026 2008 2017 2001 2003 2000 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thilo Hagen 2.7k 2.0k 875 683 475 74 4.7k
Myriam Baes 4.5k 1.7× 1.4k 0.7× 1.0k 1.2× 328 0.5× 522 1.1× 148 6.8k
Kyle L. Hoehn 4.2k 1.5× 2.6k 1.3× 872 1.0× 794 1.2× 463 1.0× 98 6.9k
Andrea Huwiler 4.8k 1.7× 1.1k 0.6× 522 0.6× 1.0k 1.5× 361 0.8× 156 6.5k
Thomas Pulinilkunnil 2.5k 0.9× 1.6k 0.8× 363 0.4× 519 0.8× 563 1.2× 80 4.7k
Joseph V. Virbasius 3.0k 1.1× 1.7k 0.8× 303 0.3× 871 1.3× 264 0.6× 25 4.9k
Philip J. Bilan 4.1k 1.5× 1.9k 1.0× 597 0.7× 1.1k 1.7× 181 0.4× 79 5.9k
Adı́lson Guilherme 2.5k 0.9× 1.8k 0.9× 306 0.3× 1.0k 1.5× 329 0.7× 43 4.7k
Tony Tiganis 5.4k 2.0× 1.8k 0.9× 648 0.7× 796 1.2× 301 0.6× 118 8.8k
C S Rubin 4.0k 1.5× 1.3k 0.7× 302 0.3× 760 1.1× 440 0.9× 57 5.7k
Lawrence Kazak 2.4k 0.9× 3.6k 1.8× 460 0.5× 813 1.2× 427 0.9× 53 5.6k

Countries citing papers authored by Thilo Hagen

Since Specialization
Citations

This map shows the geographic impact of Thilo Hagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Hagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Hagen more than expected).

Fields of papers citing papers by Thilo Hagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thilo Hagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thilo Hagen. The network helps show where Thilo Hagen may publish in the future.

Co-authorship network of co-authors of Thilo Hagen

This figure shows the co-authorship network connecting the top 25 collaborators of Thilo Hagen. A scholar is included among the top collaborators of Thilo Hagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thilo Hagen. Thilo Hagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Zhi, Gopalakrishnan Venkatesan, Sergio Rodríguez‐Cuenca, et al.. (2024). Conjugating uncoupler compounds with hydrophobic hydrocarbon chains to achieve adipose tissue selective drug accumulation. Scientific Reports. 14(1). 4932–4932.
2.
Tan, Shi Hua, et al.. (2018). Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes. PLoS ONE. 13(10). e0204853–e0204853. 24 indexed citations
3.
Wang, Mei, et al.. (2017). Activation of MAPK/ERK signaling by Burkholderia pseudomallei cycle inhibiting factor (Cif). PLoS ONE. 12(2). e0171464–e0171464. 7 indexed citations
5.
Shelar, Sandeep B., Dilip Kumar, Chong Teik Tan, et al.. (2015). Thioredoxin-dependent regulation of AIF-mediated DNA damage. Free Radical Biology and Medicine. 87. 125–136. 45 indexed citations
6.
Hagen, Thilo, et al.. (2015). 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation – Implications for targeting the Warburg effect in cancer cells. Biochemical and Biophysical Research Communications. 465(4). 838–844. 20 indexed citations
7.
Hagen, Thilo, et al.. (2013). Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases. The International Journal of Biochemistry & Cell Biology. 45(7). 1489–1498. 2 indexed citations
8.
Sethi, Jaswinder K., et al.. (2012). The Role of the Cullin-5 E3 Ubiquitin Ligase in the Regulation of Insulin Receptor Substrate-1. Biochemistry Research International. 2012. 1–8. 1 indexed citations
10.
Smith, Peter G., et al.. (2011). Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activity. Molecular Biology of the Cell. 22(24). 4706–4715. 17 indexed citations
12.
Hagen, Thilo, et al.. (2011). Regulation of Cullin RING E3 Ubiquitin Ligases by CAND1 In Vivo. PLoS ONE. 6(1). e16071–e16071. 24 indexed citations
13.
He, Hongpeng, et al.. (2010). Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia. FEBS Letters. 585(3). 492–498. 21 indexed citations
14.
Dufour, Éric, Emmanuel P. Dassa, Pierre Rustin, et al.. (2010). Stabilization of Hypoxia-inducible Factor-1α Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species Production. Journal of Biological Chemistry. 285(41). 31277–31284. 152 indexed citations
15.
Wells, Geoffrey, et al.. (2010). Heteroaromatic 4-arylquinols are novel inducers of Nuclear factor-erythroid 2-related factor 2 (Nrf2). European Journal of Pharmacology. 643(2-3). 188–194. 7 indexed citations
16.
Gan, Fei, et al.. (2009). Structure–activity analysis of 2′-modified cinnamaldehyde analogues as potential anticancer agents. Biochemical and Biophysical Research Communications. 387(4). 741–747. 23 indexed citations
17.
D’Amico, Gabriela, Francis Lam, Thilo Hagen, & Salvador Moncada. (2006). Inhibition of cellular respiration by endogenously produced carbon monoxide. Journal of Cell Science. 119(11). 2291–2298. 105 indexed citations
18.
Hagen, Thilo, Gabriela D’Amico, Marisol Quintero, et al.. (2004). Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol. Biochemical and Biophysical Research Communications. 322(3). 923–929. 66 indexed citations
19.
Hagen, Thilo & Antonio Vidal‐Puig. (2002). Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45. Biochemical and Biophysical Research Communications. 294(2). 324–328. 82 indexed citations
20.
Zhang, Chenyu, György Baffy, Pascale Perret, et al.. (2001). Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes. Cell. 105(6). 745–755. 773 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026